Summary of Recent Years
| |
2005
(IFRS) |
2004
(IFRS) |
2003
(IFRS) |
2002
(US-GAAP) |
2001
(US-GAAP) |
| Sales |
11,752 €m |
10,740 €m |
11,081 €m |
11,765 €m |
11,862 €m |
| EBITDA |
1,585 €m |
1,583 €m |
1,630 €m |
1,747 €m |
1,858 €m |
| EBITDA-Margin |
13.5% |
14.7% |
14.7% |
14.8% |
15,7% |
| EBIT |
940 €m |
931 €m |
892 €m |
939 €m |
988 €m |
| ROCE |
9.8% |
9.4% |
9.2% |
8.5% |
9.3% |
| Net Income after Minorities |
-491 €m |
298 €m |
-261 €m |
227 €m |
421 €m |
| Earnings per share |
-2.39 €m |
1.45 € |
-1.27 € |
1.10 € |
2.05 € |
| Dividend per share |
0.00 € |
1.10 € |
1.10 € |
1.10 € |
1.10 € |
| Equity ratio |
31% |
34% |
33% |
37% |
33% |
| Net Debt |
2,162 €m |
2,156 €m |
2,381 €m |
2,542 €m |
3,1 €m |
| Cashflow per share* |
5.23 €m |
5.42 € |
5.50 € |
6.95 € |
7.28 € |
| Price Earnings Ratio |
- |
21.4 |
- |
21.8 |
13.8 |
| Dividend yield |
0.00% |
3.6% |
4.0% |
4.6% |
3.9% |
* Funds from Operations
Figures for FY 2005 were adjusted for portfolio changes.
We have restated our prior-year figures to reflect the divestment of the activities grouped in the Construction Chemicals reporting segment, which was agreed in 2006. Moreover, effective 2006 our reporting segments have been redefined. Click here for an overview of the restated figures for 2005 by quarter and reporting segment.